Med-Chemist: FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

Med-Chemist : "Quintessential Medicinal Chemistry"

Monday, August 8, 2011

FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis

https://www.med-chemist.com at 4:21 PM

View web version

Contributors

Dr. Umesh..
https://www.med-chemist.com

Powered by Blogger.